Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Oral Surgery
Reference47 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA. Cancer J Clin,2018
2. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals;Fakhry;Cancer,2018
3. Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer;Argiris;J Clin Oncol,2019
4. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study;Burtness;Lancet (London, England),2019
5. Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study;Forster;Eur J Cancer,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Innovative genetic scissor strategies and their applications in cancer treatment and prevention: CRISPR modules and challenges;International Journal of Biological Macromolecules;2024-11
2. Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma;BMC Cancer;2024-04-10
3. Nicaraven attenuates the acquired radioresistance of established tumors in mouse models via PARP inhibition;Molecular and Cellular Biochemistry;2024-03-11
4. TSPO is a potential independent prognostic factor associated with cellular respiration and p16 in head and neck squamous cell carcinoma;Frontiers in Oncology;2023-12-14
5. Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy;APMIS;2023-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3